Lv51
1160 积分 2024-08-15 加入
Sovleplenib (HMPL-523), a novel Syk inhibitor, for patients with primary immune thrombocytopenia in China: a randomised, double-blind, placebo-controlled, phase 1b/2 study
3分钟前
求助中
B-cell depletion in autoimmune diseases
15天前
已完结
Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome
18天前
已完结
POEMS Syndrome
19天前
已完结
Platelet transfusion refractoriness and anti‐HLA immunization
1个月前
已完结
HLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention and management
1个月前
已完结
Fostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double‐blind, placebo‐controlled, global study (FORWARD)
1个月前
已完结
Successful treatment with daratumumab for post‐HSCT refractory hemolytic anemia
1个月前
已完结
Diagnosis and management of pemphigus: Recommendations of an international panel of experts
2个月前
已完结
Subepithelial autoimmune blistering dermatoses: Clinical features and diagnosis
2个月前
已完结
皖公网安备34019202002308
